6505--Buprenorphine Award

The Department of Veterans Affairs, through its National Acquisition Center, issued solicitation 36E79726R0004 for the supply of Buprenorphine HCL/Naloxone HCL sublingual tablets in two dosage forms—2 mg/0.5 mg and 8 mg/2 mg—each in 30-count bottles. The procurement follows FAR Part 12 commercial item procedures under NAICS code 325412 and is structured as a multi-year contract with a one-year base period and four one-year option periods, allowing for an aggregate performance window of up to five years. Offerors must comply with stringent packaging and labeling standards, including the use of non-glass containers with deshellable or convertible safety caps, minimum 120cc bottle capacity, 5.25” x 2” label dimensions, and mandatory GS1-compliant barcodes encoding the 11-digit NDC number on both immediate and outer containers. Barcodes must meet ANSI/ISO/IEC Grade C or higher quality standards and be placed to ensure scannability under normal use, with human-readable data adjacent to the barcode for VA’s BCMA systems. All products must conform to FDA cGMP regulations, USP-NF standards, and DSCSA requirements, with offerors required to certify successful stability testing across all proposed package sizes. The solicitation includes multiple FAR clauses related to small business set-asides, including 52.219-6, 52.219-7, and 52.219-27, indicating potential set-asides for small businesses, service-disabled veteran-owned small businesses, and other socioeconomically disadvantaged concerns. Subcontracting plans are required under 52.219-9, with model outlines provided, and the nonmanufacturer rule applies to ensure compliance with small business participation. Proposal submissions must be sent via email to designated VA addresses in Word or PDF format, with no zip files or faxes permitted, and must include a completed SF-1449 form, UEI and CAGE codes, NDC information, and all required certifications. The award will be made using a Lowest Priced Technically Acceptable (LPTA) methodology, evaluating technical acceptability, past performance, and cost, with the lowest-priced acceptable offer selected. The due date for offers was extended twice, from January 20, 202